Collection

COVID-19 : diagnosis, management and prognosis

Since December 2019, a new coronavirus (SARS-CoV-2) has broken into people's life, as a major public health threat worldwide. At the time of this writing, there are over 3 million people infected with SARS-CoV-2 globally and every 30 seconds someone dies from the catastrophic complications of Corona Virus Disease 2019 (COVID-19) .The body of knowledge on COVID-19 is increasing exponentially, but conflicting opinions and confusing issues dominate the scientific debate. Urgent issues to be addressed include clinical characterization across age groups, evaluation of the impact of current and novel therapeutic approaches, delineation of key risk factors, and definition of best regulatory and management decisions that are expected to ameliorate outcomes. This Topical Collection aims to expand the current knowledge base and to advance the scientific debate on COVID-19, in particular with respect to diagnosis, management and prognosis. Researches, analyses and opinions that explores phenomena, effects and mechanisms associated with COVID-19 are welcome. Researchers, academics, physicians and healthcare professionals interested in these topics are invited to submit manuscripts to this Collection

Editors

  • Riccardo Polosa

    Riccardo Polosa is Professor of Internal Medicine at the University of Catania (Italy) and Director of the department of Internal Medicine of the University Policlinic Hospital of Catania. He founded the Center of Excellence for the acceleration of HArm Reduction (CoEHAR)and the Center for Tobacco prevention and treatment (CPCT). He is also Honorary Professor of Medicine at the University of Southampton (UK) and fellow at the American Academy of Allergy, Asthma and Immunology.

  • Michele Spinicci

    Michele Spinicci is a medical doctor at the Department of Clinical and Experimental Sciences of the University of Florence in Italy.

Articles (340 in this collection)